Нозокомиальный менингит (НМ) является одним из грозных осложнений, возникающих у пациентов после черепномозговых травм и ней-рохирургических вмешательств в ... связи с раз-вившейся бактериемией. Распространённость НМ варьирует достаточно широко, составляя 0,8–17% от общего количества прооперирован-ных пациентов, а его развитие сопровождает-ся высоким риском неблагоприятного исхода. Летальность от НМ у нейрохирургических боль-ных колеблется от 20% до 50%. Диагностика строится на клинических данных, а также резуль-татах исследования ликвора, биохимического и микробиологического анализов. В данной статье представлены последние данные по этиологии, патогенезу, диагностике и лечению пациентов с нозокомиальным менингитом.
more
Hight threat in 2018-2019
Accessed: 11.03.2019
Report for WHO Meningitis guideline revision
Dr Thomas Waite, April 2014
Field Epidemiology Services, Public Health England; UK
Guide de référence rapide à l’intention des autorités sanitaires et des soignants
Révisé en 2015
Report for the WHO Meningitis Guideline Revision (May 2014)
WHO/iVB.11.09
WHO manual, 2nd edition
RBC/IHDPC/ EID Division | November2011 - The aim of the standard operating procedures is to guide health care providers and public health
experts from various levels of the health system in the implementation of enhanced surveillance of meningococcal meningitis.
В статье представлен анализ имеющихся в настоящее время возможностей диагностики бактериальных менингитов, лечения и ведения больных с этим заболеванием... с точки зрения доказательной медицины. В основу легли опубликованные результаты исследований в данной области. Приведены аргументы за и против использования соответствующих методов диагностики бактериальных менингитов, различные мнения относительно сроков начала антимикробной терапии и целесообразности использования дополнительной терапии глюкокортикоидами на основании результатов клинических исследований и их качества. Представлены современные антимикробные средства и режимы терапии бактериальных менингитов у пациентов разных возрастных категорий в зависимости от предполагаемой и подтвержденной этиологии заболевания.
more
Outline
• Welcome and objectives
• Microbiology, epidemiology and clinical presentation
• Surveillance for imported cases including case definitions
• Laboratory diagnosis • Infection prevention and hospital readiness
• Patient flow and actions required at each step
• Co-ord...inating a public health response
more
The information contained in this document, be it guidelines, recommendations, diagnostic algorithms or treatment regimens, are offered in this document in the public interest. To the best of the knowledge of the guideline writing team, the information contained in these guidelines is correct. Imple...mentation of any aspect of these guidelines remains the responsibility of the implementing agency in so far as public health liability resides, or the responsibility of the individual clinician in the case of diagnosis or treatment.
more
1. What is COVID-19?
2. Who is at most risk for COVID-19?
3. What is the risk of COVID-19 infection in humans in South Africa?
4. How is COVID-19 transmitted?
5. What are the signs and symptoms of COVID-19 infection in humans?
6. How is COVID-19 diagnosed?
7. How is COVID-19 infection ...treated?
8. How can COVID-19 infection in humans be prevented?
9. What measures have been put in place in South Africa to minimise the risk of transmission should cases be imported?
10. Should I travel now?
11. Who can I contact for more information?
more
On the 31st December 2019, the World Health Organization (WHO) China country office reported a cluster of pneumonia cases in Wuhan City, Hubei Province of China now known to be caused by a novel virus. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been confirmed as the causative v...irus of Coronavirus disease 2019 (COVID-19). Cases have now been identified in over 100 countries including South Africa.
more
For SARS-CoV-2 testing only
Defeating meningitis by 2030: a roadmap
Cryptococcal disease, particularly cryptococcal meningitis is a significant cause of morbidity and mortality among people living with HIV with advanced HIV disease. It is estimated that it is responsible for nearly 19% of AIDS-related mortality, second only to tuberculosis. Rapid screening, diagnosi...s and linking to appropriate treatment are critical actions national programs must take to reduce the burden of disease.
WHO in 2022 introduced updated guidelines for diagnosing, preventing, and managing cryptococcal disease among adults, adolescents and children living with HIV. This policy brief provides a summary of the key recommendations, clinical considerations, and also stresses the importance of ensuring access to life-saving antifungals. There is an urgent need for countries to scale-up management for not just cryptococcal meningitis, but address cryptococcal disease in the context of a package of care for advanced HIV disease as recommended by WHO.
more
Response to the tropical cyclone in southern Africa
Ebola virus disease outbreak in the Democratic Republic of the Congo
Meningitis outbreak in Togo
Lassa fever outbreak in Liberia.
A training manual for identifying, assessing, preventing and controlling the risks of pandemics in the workplace. This training manual has been developed for both medical and non-medical personnel who may be called upon to lead emergency response, (eg epidemic outbreak, etc), ensure effective conta...inment whiles work continues and essential goods and services continue to be supplied.
The manual provides insight into some of the local epidemics experienced in Ghana such as Cholera, Cerebrospinal meningitis (CSM) and Influenza(s), the causes, signs and symptoms and preventive measures with a view to increasing knowledge among management, staff and their families as well as immediate communities within which they work.
more
Antimicrobial resistant (AMR) organisms are increasing globally, threatening to render existing treatments ineffective against many infectious diseases. In Africa, AMR has already been documented to be a problem for HIV and the pathogens that cause malaria, tuberculosis, typhoid, cholera, meningitis..., gonorrhea, and dysentery. Recognizing the urgent need for action, the World Health Assembly adopted the Global Action Plan on Antimicrobial Resistance in May 2015. In accordance with the Global Action Plan and to meet needs specific to Africa, Africa CDC will establish the Anti-Microbial Resistance Surveillance Network (AMRSNET). AMRSNET is a network of public health institutions and leaders from human and animal health sectors who will collaborate to measure, prevent, and mitigate harms from AMR organisms.
more